Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '584 review

Re: '584 review

in response to by
posted on Jul 07, 2007 03:59PM
Another good post SGE.... however I will say that it is still possible that the USPTO can rule in a similar fashion on claims in the 148 and 336... we just don't know. So far, only claim 29 of the 584 is being questioned but that doesn't preclude other claims in the 148 or 336 to be questioned in the future. It would be great if this is all we get from them, but I'm not sure the process is complete.
Share
New Message
Please login to post a reply